HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.

Abstract
Follicular thyroid cancer (FTC) is known to metastasize to distant sites via hematogenous spread; however, the underlying pathways that contribute to metastasis remain unknown. Recent creation of a knockin mutant mouse that expresses a mutant thyroid hormone receptor-beta (TRbeta(PV/PV) mouse) that spontaneously develops thyroid cancer with metastasis similar to humans has provided new opportunities to study contributors to FTC metastasis. This study evaluates the role of gelsolin, an actin-regulatory protein, in modulating the metastatic potential of FTC. Gelsolin was previously found by cDNA microarray analysis to be down-regulated in TRbeta(PV/PV) mice as compared with wild-type mice. This study found an age-dependent reduction of gelsolin protein abundance in TRbeta(PV/PV) mice as tumorigenesis progressed. Knockdown of gelsolin by small interfering RNA resulted in increased tumor cell motility and increased gelsolin expression by histone deacetylase inhibitor (trichostatin A) led to decreased cell motility. Additional biochemical analyses demonstrated that gelsolin physically interacted with TRbeta1 or PV in vivo and in vitro. The interaction regions were mapped to the C terminus of gelsolin and the DNA binding domain of TR. The physical interaction of gelsolin with PV reduced its binding to actin, leading to disarrayed cytoskeletal architectures. These results suggest that PV-induced alteration of the actin/gelsolin cytoskeleton contributes to increased cell motility. Thus, the present study uncovered a novel PV-mediated oncogenic pathway that could contribute to the local tumor progression and metastatic potential of thyroid carcinogenesis.
AuthorsCaroline S Kim, Fumihiko Furuya, Hao Ying, Yasuhito Kato, John A Hanover, Sheue-yann Cheng
JournalEndocrinology (Endocrinology) Vol. 148 Issue 3 Pg. 1306-12 (Mar 2007) ISSN: 0013-7227 [Print] United States
PMID17170101 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Actins
  • Gelsolin
  • Mutant Proteins
  • Thyroid Hormone Receptors beta
Topics
  • Actins (metabolism)
  • Animals
  • Carcinoma, Papillary, Follicular (pathology)
  • Cell Movement (genetics)
  • Cells, Cultured
  • Chlorocebus aethiops
  • Disease Models, Animal
  • Disease Progression
  • Gelsolin (metabolism, physiology)
  • Mice
  • Mice, Transgenic
  • Mutant Proteins (metabolism)
  • Protein Binding
  • Thyroid Gland (metabolism)
  • Thyroid Hormone Receptors beta (genetics, metabolism)
  • Thyroid Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: